AI assistant
Sending…
ANAPTYSBIO, INC — Director's Dealing 2021
Feb 13, 2021
32596_dirs_2021-02-12_045fda63-b26a-413b-8ae0-198a8f2509b9.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ANAPTYSBIO, INC (ANAB)
CIK: 0001370053
Period of Report: 2021-02-10
Reporting Person: Marquet Magda (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-02-10 | Stock Option (right to buy) | $29.70 | A | 11000 | Acquired | 2031-02-09 | Common Stock (11000) | Direct |
Footnotes
F1: The stock option vests as of 1/12 of the total shares monthly beginning on March 10, 2021 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.
More from ANAPTYSBIO, INC
Regulatory Filings
2026
May 29
Regulatory Filings
2026
May 21
Regulatory Filings
2026
Apr 20
Director's Dealing
2026
Mar 28
Regulatory Filings
2026
Mar 27
Major Shareholding Notification
2026
Mar 26
Annual Report
2026
Mar 3
Regulatory Filings
2026
Mar 3
Director's Dealing
2026
Feb 13
Major Shareholding Notification
2026
Jan 16